Long-Term Safety and Efficacy of Upadacitinib (ABT-494), an Oral JAK-1 Inhibitor in Patients with Rheumatoid Arthritis in an Open Label Extension Study Genovese, M. C., Kremer, J., Zhong, S., Friedman, A. WILEY. 2017

View details for Web of Science ID 000411824100508